Biologics Research Review, Issue 26 - Rheumatology focus

In this issue:

Long-term efficacy and safety of secukinumab in PsA
Iscalimab for primary Sjögren’s syndrome
Serious infection with tofacitinib vs biologic DMARDs
Discontinuation of methotrexate in RA patients treated with tocilizumab
Cardiovascular safety of tocilizumab
Radiographic progression across levels of PsA activity with golimumab
Discontinuation of certolizumab pegol in early RA
Golimumab plus methotrexate for dactylitis
A TLR4 antibody for RA
Biologic vs conventional synthetic DMARDs in RA patients with COPD

Please login below to download this issue (PDF)

Subscribe